Hepatic cholesterol metabolism in experimental nephrotic syndrome

Ayman Al-Shurbaji, Elisabet Humble, Mats Rudling, Bernhard Lindenthal, Lars Berglund

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Hypercholesterolemia is a consistent feature of the nephrotic syndrome. However, the mechanisms underlying this perturbation are unclear. In the present work, we have investigated different factors that influence hepatic cholesterol metabolism using the nephrotic rat as a model. The induction of nephrosis resulted in a severe and sustained hypercholesterolemia. However, no effect on the rate-limiting enzyme in cholesterol synthesis, 3-hydroxy-3- methylglutaryl CoA reductase, could be detected. Further, plasma lathosterol/cholesterol ratio, a measure of cholesterol synthesis, was not altered. Also, plasma levels of mevalonate, both a substrate for cholesterogenesis beyond the rate-limiting step and a marker for cholesterol synthesis, did not differ between control rats and those with established hypercholesterolemia. There was no detectable change in the expression of low density lipoprotein (LDL) receptor between the two experimental groups. We conclude that the early increase in cholesterol synthesis reported after the induction of nephrosis is not necessary for the maintenance of hypercholesterolemia. Established hypercholesterolemia of the nephrotic syndrome seems to represent a steady state in which neither enhanced hepatic cholesterol synthesis nor retarded LDL cholesterol clearance is of major importance.

Original languageEnglish (US)
Pages (from-to)165-169
Number of pages5
JournalLipids
Volume33
Issue number2
DOIs
StatePublished - 1998
Externally publishedYes

Fingerprint

nephrotic syndrome
cholesterol metabolism
Nephrotic Syndrome
Metabolism
hypercholesterolemia
Cholesterol
cholesterol
Hypercholesterolemia
liver
Liver
synthesis
nephrosis
Nephrosis
Rat control
Hydroxymethylglutaryl CoA Reductases
Plasmas
rats
Mevalonic Acid
low density lipoprotein
low density lipoprotein cholesterol

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Food Science
  • Biochemistry

Cite this

Hepatic cholesterol metabolism in experimental nephrotic syndrome. / Al-Shurbaji, Ayman; Humble, Elisabet; Rudling, Mats; Lindenthal, Bernhard; Berglund, Lars.

In: Lipids, Vol. 33, No. 2, 1998, p. 165-169.

Research output: Contribution to journalArticle

Al-Shurbaji, A, Humble, E, Rudling, M, Lindenthal, B & Berglund, L 1998, 'Hepatic cholesterol metabolism in experimental nephrotic syndrome', Lipids, vol. 33, no. 2, pp. 165-169. https://doi.org/10.1007/s11745-998-0192-z
Al-Shurbaji, Ayman ; Humble, Elisabet ; Rudling, Mats ; Lindenthal, Bernhard ; Berglund, Lars. / Hepatic cholesterol metabolism in experimental nephrotic syndrome. In: Lipids. 1998 ; Vol. 33, No. 2. pp. 165-169.
@article{e50fb7bb3f6742b1952c867ad055f703,
title = "Hepatic cholesterol metabolism in experimental nephrotic syndrome",
abstract = "Hypercholesterolemia is a consistent feature of the nephrotic syndrome. However, the mechanisms underlying this perturbation are unclear. In the present work, we have investigated different factors that influence hepatic cholesterol metabolism using the nephrotic rat as a model. The induction of nephrosis resulted in a severe and sustained hypercholesterolemia. However, no effect on the rate-limiting enzyme in cholesterol synthesis, 3-hydroxy-3- methylglutaryl CoA reductase, could be detected. Further, plasma lathosterol/cholesterol ratio, a measure of cholesterol synthesis, was not altered. Also, plasma levels of mevalonate, both a substrate for cholesterogenesis beyond the rate-limiting step and a marker for cholesterol synthesis, did not differ between control rats and those with established hypercholesterolemia. There was no detectable change in the expression of low density lipoprotein (LDL) receptor between the two experimental groups. We conclude that the early increase in cholesterol synthesis reported after the induction of nephrosis is not necessary for the maintenance of hypercholesterolemia. Established hypercholesterolemia of the nephrotic syndrome seems to represent a steady state in which neither enhanced hepatic cholesterol synthesis nor retarded LDL cholesterol clearance is of major importance.",
author = "Ayman Al-Shurbaji and Elisabet Humble and Mats Rudling and Bernhard Lindenthal and Lars Berglund",
year = "1998",
doi = "10.1007/s11745-998-0192-z",
language = "English (US)",
volume = "33",
pages = "165--169",
journal = "Lipids",
issn = "0024-4201",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Hepatic cholesterol metabolism in experimental nephrotic syndrome

AU - Al-Shurbaji, Ayman

AU - Humble, Elisabet

AU - Rudling, Mats

AU - Lindenthal, Bernhard

AU - Berglund, Lars

PY - 1998

Y1 - 1998

N2 - Hypercholesterolemia is a consistent feature of the nephrotic syndrome. However, the mechanisms underlying this perturbation are unclear. In the present work, we have investigated different factors that influence hepatic cholesterol metabolism using the nephrotic rat as a model. The induction of nephrosis resulted in a severe and sustained hypercholesterolemia. However, no effect on the rate-limiting enzyme in cholesterol synthesis, 3-hydroxy-3- methylglutaryl CoA reductase, could be detected. Further, plasma lathosterol/cholesterol ratio, a measure of cholesterol synthesis, was not altered. Also, plasma levels of mevalonate, both a substrate for cholesterogenesis beyond the rate-limiting step and a marker for cholesterol synthesis, did not differ between control rats and those with established hypercholesterolemia. There was no detectable change in the expression of low density lipoprotein (LDL) receptor between the two experimental groups. We conclude that the early increase in cholesterol synthesis reported after the induction of nephrosis is not necessary for the maintenance of hypercholesterolemia. Established hypercholesterolemia of the nephrotic syndrome seems to represent a steady state in which neither enhanced hepatic cholesterol synthesis nor retarded LDL cholesterol clearance is of major importance.

AB - Hypercholesterolemia is a consistent feature of the nephrotic syndrome. However, the mechanisms underlying this perturbation are unclear. In the present work, we have investigated different factors that influence hepatic cholesterol metabolism using the nephrotic rat as a model. The induction of nephrosis resulted in a severe and sustained hypercholesterolemia. However, no effect on the rate-limiting enzyme in cholesterol synthesis, 3-hydroxy-3- methylglutaryl CoA reductase, could be detected. Further, plasma lathosterol/cholesterol ratio, a measure of cholesterol synthesis, was not altered. Also, plasma levels of mevalonate, both a substrate for cholesterogenesis beyond the rate-limiting step and a marker for cholesterol synthesis, did not differ between control rats and those with established hypercholesterolemia. There was no detectable change in the expression of low density lipoprotein (LDL) receptor between the two experimental groups. We conclude that the early increase in cholesterol synthesis reported after the induction of nephrosis is not necessary for the maintenance of hypercholesterolemia. Established hypercholesterolemia of the nephrotic syndrome seems to represent a steady state in which neither enhanced hepatic cholesterol synthesis nor retarded LDL cholesterol clearance is of major importance.

UR - http://www.scopus.com/inward/record.url?scp=0031881594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031881594&partnerID=8YFLogxK

U2 - 10.1007/s11745-998-0192-z

DO - 10.1007/s11745-998-0192-z

M3 - Article

C2 - 9507238

AN - SCOPUS:0031881594

VL - 33

SP - 165

EP - 169

JO - Lipids

JF - Lipids

SN - 0024-4201

IS - 2

ER -